Navigation Links
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Date:6/23/2011

AMSTERDAM, June 24, 2011 /PRNewswire/ --


 

- Dossier Re-Examination Process Initiated

Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it has received an opinion on its Marketing Authorisation Application (MAA) for Glybera® (alipogene tiparvovec) as a potential therapy for Lipoprotein Lipase Deficiency ("LPLD"). Following a recent meeting with the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP), AMT has been notified that, at this time, Glybera is not approvable.

Subsequent to a review of the CHMP's letter, AMT believes that Glybera can receive a positive opinion subject to generating additional data from existing patients. AMT has therefore decided to ask for a re-examination of the clinical data package.

"From what we know today, despite the disappointment, we believe that there is an indication from the CHMP that Glybera could receive approval and that the current opinion at this time is a reflection of insufficient proof of clinical benefit of Glybera as a result of low patient numbers measured for chylomicron handling for at least 12 months post treatment. The CHMP also indicated that if certain additional data from already treated patients would confirm current results by the end of 2011, an approval may be possible," noted Jörn Aldag, CEO of AMT. "In the dossier, we provided important data showing Glybera is safe and prevents episodes of pancreatitis, the major clinical complication of LPLD. We appreciate the CHMP's responsibility for caution on such an advanced therapy, so we will work diligently to generate more information and, we hope, ensure that Glybera will still reach patients."

Next steps

As part of the MAA, AMT presented data to the CHMP on Glybera showing evidence in reducing the risk of pancreatitis. Also, the company demonstrated a clear signal of patients' ability to b
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharma and Food Thought Leaders Set to Converge in Amsterdam Next April 2011
2. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
3. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
4. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
5. Data from Clinical Studies of bioTheranostics CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
6. ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
7. Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia
8. The World Leader in Molecular Breast Imaging to Premiere Largest Detector in the Industry
9. Gen-Probe Files for US Regulatory Clearance of PANTHER™ System, Fully Automated and Integrated Molecular Testing Instrument
10. Latest Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging (MBI)
11. Cepheid Extends Rapid Molecular Diagnostics Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 Tissue ... the regenerative medical devices company, announces that it ... wound care market as Tissue Regenix Wound Care ... Medicare administrator, First Coast Service Options Inc. ("First ... , Puerto Rico and ...
(Date:7/29/2015)... , July 30, 2015 ... Guidance   for ... Core Earnings and Core ... Highlights of Q1 results  ... Underlying core earnings and underlying core EPS were flat, year-to-year , ...
(Date:7/29/2015)... , July 29, 2015 Insulet Corporation (NASDAQ: ... technology with its OmniPod ® Insulin Management System, ... ended June 30, 2015. The Company also announced that ... quarter financial results and conference call from Thursday, July ... Second Quarter Revenue Highlights: , ...
Breaking Medicine Technology:Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 2Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 2Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 4Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 5Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5
... and Physician,Reports that Children with Autism Spectrum ... Fever, BALTIMORE, Dec. 3 Over ... observed that the behaviors of children with,autism ... rather,dramatically, during a fever. Longer concentration spans, ...
... World AIDS,Day 2007, CHF International is honoring the struggle ... HIV/AIDS, but calls for greater,international support of grassroots, community-based ... decades, international assistance has made a marked,impact in helping ... means that more people are able to treat their ...
Cached Medicine Technology:Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders 2Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders 3Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders 4On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS 2On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS 3
(Date:7/30/2015)... ... July 30, 2015 , ... After a three year trial designed to ... commonly known as the “bionic eye,” researchers have determined the trial to be a ... patients facing or already affected by complete vision loss as a result of Retinitis ...
(Date:7/30/2015)... IL (PRWEB) , ... July 30, 2015 , ... ... patients are living longer and do not find a complete removable denture acceptable. ... standard of care. The practices that incorporate less expensive, immediate loading techniques will ...
(Date:7/30/2015)... ... ... gain weight, many people place a lot of focus on the different types of food that ... However, another key component to successful weight gain is knowing when to eat so ... Weight Gainer gives three tips on when to eat to gain weight. , The first ...
(Date:7/30/2015)... ... ... PeopleKeys, a company with over 30 years of experience in behavioral analysis, ... the newest installment in their popular DISC for the Real World series, will air ... webinar is intended for people interested in training others to use DISC behavioral analysis ...
(Date:7/29/2015)... ... July 30, 2015 , ... Macro Wealth Management ... through the Smile for a Lifetime program by encouraging their clients to donate their ... by MWM Presidents Dr. Mart McClellan and Tim Streid, who see charitable giving as ...
Breaking Medicine News(10 mins):Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 2Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 3Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:Smile for a Lifetime (S4L) Partners with Macro Wealth Management (MWM) Helping More Children Get Braces 2
... for the first time, identified Apolipoprotein E (APOE), ... disease in adults, can also increase the likelihood ... ,This is the first identification of a ... of the study, published in the February issue ...
... out by non-profit National Institute of Cancer Research delving into ... treatment of cancer has come out with significant findings. ... show that a low fat diet can decrease the recurrence ... receptor(ER)- negative breast cancer. ,The study was carried ...
... that are cloned will not bear any labels to signify ... consumption, there is no necessary to indicate its source. // ... U.S. Government on consumption of food from cloned animals is ... will evaluate and consider the public’s comments on this issue ...
... without taking a break has helped a doctor here to ... technique of single hole surgery. ,Doctor Ajay Prakash ... around 10 p.m. Thursday night and continued surgeries without a ... and five appendixes, with his surgery technique, which he describes ...
... this number to your need-to-know file: your body mass index.// ... cholesterol level, your body mass index (BMI) has an impact ... type 2 diabetes and some cancers. With a lower BMI, ... of blood sugar and cholesterol. ,Mayo Clinic’s ...
... benefits of mammogram screenings because the results are not ... Public Health researchers in the March issue of American ... reduce death and disability from breast cancer, the second ... current guidelines recommend routine mammography screening for women aged ...
Cached Medicine News:Health News:Newborns' Cerebral Palsy Risk Increased By Alzheimer's Gene 2Health News:Body Mass Index: Do You Know Yours? 2Health News:Inadequate Communication Reduces Benefits of Mammogram Screening for Black Women 2
... These versatile enclosures ... with nitrogen or other ... a low-humidity environment. HEPA ... and ionization modules also ...
Ideal for chemical processing that requires downward flow of exhaust fumes. Powderful 1200 CFM blower draws fumes into sub-surface bonded charcoal filter for safe removal of organic vapors (final HEP...
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... fume hood ventilates and purifies ... release of exhaust. Bonded charcoal ... Configurations are available with vertical ... final HEPA filter, work bench ...
Medicine Products: